Convelotx
Cleveland, US · 1 known investors
Convelo Therapeutics develops remyelination-enhancing therapies targeting multiple sclerosis by activating oligodendrocytes to repair nerve damage in the central nervous system. The company aims to enable myelin regeneration and restore function for MS patients.
BiotechDigital HealthMedical Devices
Founders & leadership
PT
Paul TesarCo-founder, Professor
DA
Drew AdamsCo-founder, Professor
DR
Derrick RossiCEO